In the last week, Pfizer/BioNTech and Moderna both announced results from two COVID-19 Phase 3 clinical trials showing efficacy of greater than 90 percent. According to company press releases, the trials showed no significant safety issues. (Full publication of the...
To follow up on “Navigating COVID-19: A Briefing for Leaders,” which we posted last week, we’ve created two downloadable, printable references to keep handy as you prepare communications related to COVID-19....
Around the globe, we are navigating unprecedented territory. In response to the coronavirus 2019 pandemic, borders have closed, Main Streets have shuttered and millions of people are working from home—many alongside their children, who are figuring out how to go to...
Communicating scientific information is complex. Most of us aren’t scientific experts, otherwise there would be a lot more science in the world. Scientific information is also constantly evolving. Our understanding of the impacts of climate change has evolved dramatically in...
It’s been awfully quiet on the Orangefiery blog. Too quiet. Fifteen months since our last post? That’s outrageous! All we can offer is a typical excuse: We’ve been really busy. It’s true. Business is good and growing. We’ve got a dozen clients...
Years ago, I was part of a team that was hired to help a pharmaceutical company explain to America why its industry was a good thing. This was not an easy task, obviously. The pharmaceutical industry has a weak reputation overall,...
I live in Marin County, Calif., just north of San Francisco via the Golden Gate Bridge. It is one of the most strikingly beautiful places I’ve ever seen, and I’ve seen a lot of beautiful places. With a median income...
